A 26-year-old primigravida at 33 weeks asks about RSV prevention for her newborn. What is true about maternal RSV vaccination and infant monoclonal an...

Question

A 26-year-old primigravida at 33 weeks asks about RSV prevention for her newborn. What is true about maternal RSV vaccination and infant monoclonal antibody?

Accepted Answer

Either maternal RSV vaccine at 32-36 weeks or infant nirsevimab is recommended; both are not routinely given together

Answer

Both should be routinely given to maximise protection

Answer

Only nirsevimab is recommended; maternal vaccination is contraindicated

Answer

Vaccination must be at 28-30 weeks to be effective

Answer

Give palivizumab to all infants regardless of risk

us-abfm MCQ (SBA): RSV Prevention (Maternal vs Infant)

A 26-year-old primigravida at 33 weeks asks about RSV prevention for her newborn. What is true about maternal RSV vaccination and infant monoclonal antibody?